October 21, 2022 – The CDC cleared a third vaccine-maker’s COVID-19 booster for authorization in the U.S. on Oct. 19 following the FDA’s vote.
Novavax’s monovalent booster is authorized for adults 18 and older, and the CDC said the decision offers another option for those who have completed the primary vaccination series but have not received a booster shot. It also could interest those who are wary of mRNA-based vaccines, like Pfizer’s and Moderna’s shots, CDC Director Rochelle Walensky, MD, said in a statement.
According to the CDC COVID-19 tracker, 68.1 percent of the nation’s population has completed a primary series and 49 percent has gotten a booster shot.